Hydroxychloroquine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial
ConclusionsAlthough the efficacy of PrEP with hydroxychloroquine for preventing COVID-19 could not be evaluated, our study showed that PrEP with hydroxychloroquine at low doses is safe.Trial registrationClinicalTrials.govNCT04331834. Registered on April 2, 2020. (Source: Trials)
Source: Trials - November 15, 2021 Category: Research Source Type: clinical trials

HCQ for Non Europeans With Mild to Severe UC
Condition:   Ulcerative Colitis (Disorder) Interventions:   Drug: Hydroxychloroquine;   Drug: Mesalamine Sponsors:   Icahn School of Medicine at Mount Sinai;   Crohn's and Colitis Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 12, 2021 Category: Research Source Type: clinical trials